AstraZeneca pulls EU lung cancer drug application

AstraZeneca and Daiichi Sankyo announced on Tuesday that they are withdrawing “voluntarily” the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd).The drug targe…